Quest Diagnostics targets $10.7B-$10.85B 2025 revenue with focus on advanced diagnostics and acquisitions
CEO Jim Davis reported a nearly 15% revenue growth for Q4, including 5% organic growth, and close to 7% revenue growth for the full year, supported by eight acquisitions. He highlighted the Advanced ...
Elevance Health: Trading At Depressed Levels, So We Added Modestly
We took advantage of Elevance Health's share price weakness in the fourth quarter and added modestly to our investment. Click ...